| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = -$488,022 ) |
| | 2019 | 2015 | SIGA TECHNOLOGIES, INC. | 31 E 62ND ST | NEW YORK | NY | 10065-8014 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 5 | NIH | 11/30/2018 | -$488,022 |
|
| Issue Date FY: 2017 ( Subtotal = -$28,275 ) |
| | 2017 | 2015 | SIGA TECHNOLOGIES, INC. | 660 MADISON AVE STE 1700 | NEW YORK | NY | 10065-8446 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 5 | NIH | 4/13/2017 | $0 |
| | 2017 | 2013 | SIGA TECHNOLOGIES, INC. | 27 E 62ND ST | NEW YORK | NY | 10065-8014 | NEW YORK | USA | R01AI093387 | Antiviral Drugs for Arenaviruses | 000 | 3 | NIH | 3/20/2017 | -$28,275 |
|
| Issue Date FY: 2015 ( Subtotal = $1,192,443 ) |
| | 2015 | 2015 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 5 | NIH | 5/15/2015 | $1,192,443 |
|
| Issue Date FY: 2014 ( Subtotal = $1,246,033 ) |
| | 2014 | 2014 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 4 | NIH | 4/9/2014 | $1,246,033 |
|
| Issue Date FY: 2013 ( Subtotal = $2,517,040 ) |
| | 2013 | 2013 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 3 | NIH | 4/22/2013 | $1,103,068 |
| | 2013 | 2013 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 001 | 3 | NIH | 6/13/2013 | $49,025 |
| | 2013 | 2013 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093387 | Antiviral Drugs for Arenaviruses | 000 | 3 | NIH | 7/1/2013 | $1,364,947 |
|
| Issue Date FY: 2012 ( Subtotal = $2,695,987 ) |
| | 2012 | 2012 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 2 | NIH | 4/19/2012 | $1,260,044 |
| | 2012 | 2012 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093387 | Antiviral Drugs for Arenaviruses | 000 | 2 | NIH | 7/18/2012 | $1,435,943 |
|
| Issue Date FY: 2011 ( Subtotal = $4,222,011 ) |
| | 2011 | 2011 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R44AI075747 | ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS | 000 | 5 | NIH | 8/10/2011 | $1,000,000 |
| | 2011 | 2011 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093387 | Antiviral Drugs for Arenaviruses | 000 | 1 | NIH | 8/17/2011 | $1,779,213 |
| | 2011 | 2011 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R01AI093356 | Antiviral therapeutics for flavivirus infections | 000 | 1 | NIH | 5/3/2011 | $1,442,798 |
|
| Issue Date FY: 2010 ( Subtotal = $1,492,557 ) |
| | 2010 | 2010 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R44AI075747 | ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS | 001 | 4 | NIH | 8/9/2010 | $999,979 |
| | 2010 | 2010 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | U01AI082108 | BROAD-SPECTRUM, SMALL-MOLECULE INHIBITORS OF BUNYAVIRUSES | 000 | 2 | NIH | 8/30/2010 | $492,578 |
| | 2010 | 2009 | SIGA TECHNOLOGIES, INC | 35 EAST 62ND STREET | NEW YORK | NY | 10065 | NEW YORK | USA | R44AI075747 | ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS | 000 | 3 | NIH | 11/24/2009 | $0 |
| | 2010 | 2008 | SIGA TECHNOLOGIES, INC | 35 EAST 62ND STREET | NEW YORK | NY | 10065 | NEW YORK | USA | R44AI056525 | ANTIVIRAL DRUGS FOR LASSA FEVER VIRUS | 000 | 7 | NIH | 3/5/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $2,734,182 ) |
| | 2009 | 2009 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R43AI079937 | NOVEL SMALL MOLECULE INHIBITORS OF DENGUE REPLICATION | 001 | 2 | NIH | 7/21/2009 | $559,265 |
| | 2009 | 2009 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | U01AI082108 | BROAD-SPECTRUM, SMALL-MOLECULE INHIBITORS OF BUNYAVIRUSES | 000 | 1 | NIH | 9/18/2009 | $1,174,957 |
| | 2009 | 2009 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170-0499 | NEW YORK | USA | R44AI075747 | ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS | 000 | 3 | NIH | 8/28/2009 | $999,960 |
| | 2009 | 2008 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170 | NEW YORK | USA | R43AI079937 | NOVEL SMALL MOLECULE INHIBITORS OF DENGUE REPLICATION | 000 | 1 | NIH | 3/23/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $6,736,665 ) |
| | 2008 | 2008 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170 | NEW YORK | USA | R43AI072905 | ENHANCING THE IMMUNE RESPONSE TO ANTIGENS DELIVERED BY THE BACTERIAL VECTOR, STRE | 000 | 2 | NIH | 7/29/2008 | $280,538 |
| | 2008 | 2008 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170 | NEW YORK | USA | R44AI056525 | ANTIVIRAL DRUGS FOR LASSA FEVER VIRUS | 000 | 7 | NIH | 8/18/2008 | $3,901,282 |
| | 2008 | 2008 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170 | NEW YORK | USA | R43AI075747 | ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS IN MURINE MODELS | 000 | 2 | NIH | 7/29/2008 | $321,291 |
| | 2008 | 2008 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170 | NEW YORK | USA | R43AI079937 | NOVEL SMALL MOLECULE INHIBITORS OF DENGUE REPLICATION | 000 | 1 | NIH | 8/18/2008 | $404,472 |
| | 2008 | 2008 | SIGA TECHNOLOGIES, INC | 420 LEXINGTON AVENUE | NEW YORK | NY | 10170 | NEW YORK | USA | R44AI056409 | SMALL MOLECULE INHIBITORS OF SMALLPOX VIRUS REPLICATION | 000 | 7 | NIH | 7/29/2008 | $1,829,082 |
|
| Issue Date FY: 2007 ( Subtotal = $3,479,719 ) |
| | 2007 | 2007 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R44AI056525 | ANTIVIRAL DRUGS FOR LASSA FEVER VIRUS | 000 | 6 | NIH | 8/30/2007 | $1,160,831 |
| | 2007 | 2007 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R44AI056409 | SMALL MOLECULE INHIBITORS OF SMALLPOX VIRUS REPLICATION | 000 | 6 | NIH | 8/13/2007 | $1,751,533 |
| | 2007 | 2007 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R43AI072905 | ENHANCING THE IMMUNE RESPONSE TO ANTIGENS DELIVERED BY THE BACTERIAL VECTOR, STRE | 000 | 1 | NIH | 9/4/2007 | $273,956 |
| | 2007 | 2007 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R43AI075747 | ST-246 TREATMENT OF SMALLPOX VACCINE-RELATED ADVERSE EVENTS IN MURINE MODELS | 000 | 1 | NIH | 7/30/2007 | $293,399 |
|
| Issue Date FY: 2006 ( Subtotal = $2,979,997 ) |
| | 2006 | 2006 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R43AI060094 | BACTERIAL COMMENSAL VECTOR DELIVERY/SMALLPOX VACCINE | 000 | 1 | NIH | 2/27/2006 | $491,430 |
| | 2006 | 2006 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R44AI056409 | SMALL MOLECULE INHIBITORS OF SMALLPOX VIRUS REPLICATION | 000 | 5 | NIH | 8/1/2006 | $1,513,613 |
| | 2006 | 2006 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R44AI056525 | ANTIVIRAL DRUGS FOR LASSA FEVER VIRUS | 000 | 5 | NIH | 8/31/2006 | $974,954 |
|
| Issue Date FY: 2005 ( Subtotal = $6,127,315 ) |
| | 2005 | 2005 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R44AI056525 | ANTIVIRAL DRUGS FOR LASSA FEVER VIRUS | 000 | 4 | NIH | 9/9/2005 | $3,214,689 |
| | 2005 | 2005 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R44AI056409 | SMALL MOLECULE INHIBITORS OF SMALLPOX VIRUS REPLICATION | 000 | 4 | NIH | 8/18/2005 | $2,912,626 |
|
| Issue Date FY: 2004 ( Subtotal = $4,522,548 ) (Continued on the next page) |
| | 2004 | 2004 | SIGA TECHNOLOGIES, INC | 4575 SW RESEARCH WAY SUITE 230 | CORVALLIS | OR | 97333 | BENTON | USA | R41AI058382 | LACTOCOCCAL VACCINE FOR STREP THROAT | 000 | 1 | NIH | 7/26/2004 | $252,038 |
|
| Loading… |
|
